Skip to main content

First Roundup Trial Set To Begin on February 25, 2019

First Roundup Trial Set To Begin on February 25, 2019

First Roundup Trial Set To Begin on February 25, 2019

Introduction

In a pretrial order submitted on October 3, 2018, the U.S. District Judge presiding over all Roundup lawsuits filed against the weed killer manufacturer Monsanto, outlined deadlines ahead of the first trial to be held in the federal litigation. The jury selection in the first case would commence on February 20, 2019, followed by the first trial which has been scheduled for February 25.

As per the order, case-specific discovery for each plaintiff will be finished by November 20, and expert discovery will be concluded by December 20. The parties are required to file any challenges to the admissibility of expert testimony and motions for summary judgment at the most by January 3, 2019.

Monsanto currently faces about 800 product liability cases filed by farmworkers, landscapers and other consumers who were allegedly diagnosed with Non-Hodgkins lymphoma (NHL) due to glyphosate exposure in Roundup. Similar lawsuits are consolidated as a part of a multidistrict litigation (MDL No. 2741; In Re: Roundup Products Liability Litigation), presided over by Judge Vince Chhabria, in the U.S. District Court of  San Francisco.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.